Drug Reduces Mysterious Particle Involved in Heart Attack Risk
The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...
Healio35m
Lepodisiran lowers Lp(a) substantially with infrequent administration
CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...
Altria: Smoke-Free Ambitions On Hold (Rating Downgrade)
Altria faces challenges in the vape market and valuation pressure, but its 7% dividend yield and tariff insulation offer ...